IMAX: Is The Hype Worth It?
- Meher Mehta
- Jan 20
- 4 min read
Company Overview
With streaming firms like Netflix, Amazon Prime, HBO Max and even YouTube dominating the movie space, it’s no question why people wonder if the age of cinema & theaters is over. However, a stock in this very space has recently caught the eye of some investors. IMAX Corporation (NYSE: IMAX). has been making headlines with impressive performance in the past week, but how much of this newfound acclaim is worth it?
IMAX, founded in 1967 and publicly traded since 1994, is a part of the entertainment industry in the communication services sector. It’s a global company (operating in countries like the United States, Canada, China, and many more) that provides content solutions like motion picture technologies & presentations to consumers. The company’s technologies have been credited for revolutionizing the cinema experience, especially in the United States. The company’s business model consists of remastering films into their proprietary format and selling/leasing IMAX technologies globally.
The primary shift in IMAX’s current growth has been a revision of its future earnings. Analysts are targeting higher estimates, likely because IMAX has beat earnings estimates for the first three quarters of the 2025 fiscal year.
There have been a few different catalysts for these analyst updates. IMAX reported its historical best year at the end of 2025, with 3.8% global box office share made by its record $1.28 billion. Something that helps IMAX’s position is the fact that they have a relatively asset-light model, making it less capital intensive and giving it better free cash flow (FCF) conversion rates. The latter is important because it shows how sustainable a company’s profits are. FCF shows the amount of earnings a company has to pursue activities such as debt repayment or reinvestment. This key indicator is favorable for IMAX, as it shows that it [currently] has strong financial health.
Another factor has been the corporation’s high operating leverage. Operating leverage gives a prediction of a company’s increases in operating income through revenue increases; it also typically means their variable costs will be lower. High operating leverage allows companies to benefit when sales increase although there may be added risks in case forecasts are inaccurate (and fixed costs also tend to be higher). This means that if sales continue to increase for IMAX as they did in the first three quarters of 2025, the company will become more profitable.
While the catalysts are strong, it is necessary to consider the risks for investing in the stock. While there are natural risks with market volatility, perhaps the main risk for IMAX would be the one mentioned at the start: the decline of theaters in the face of streaming services. Moreover, the recent battle for Warner Bros (NASDAQ: WBD), with Netflix (NASDAQ: NFLX) has raised a plethora of questions regarding the cinema landscape going forward. Warner Bros’ content (including upcoming) will be brought to Netflix users. With Netflix’ notoriety in the entertainment space, it is clear to see why this has caused worry for the future of companies such as IMAX. Does it mean that the catalysts above may be worthless in the face of these projected changes?
Something that may be an important mitigant is actually IMAX’s services themselves. IMAX’s proprietary technologies have made it adaptable to such changes in the market, and there are still spaces for the company to take advantage of. With trends such as global languages & event-driven movies becoming more widespread, it’s more than possible for an innovative company like IMAX to take advantage of them. Moreover, their mixed model (leasing or selling) shows that they are clearly well adapted to consumer needs globally. This factor positions them favorably as the landscape of the cinema space continues to change. While there is still ambiguity, it appears that IMAX is well positioned to take on these changes.
Financials
The company’s financials also appear to support its positioning. IMAX made $377.68 million in revenue and earned $39.55 million in profit, highlighting its healthy overall performance. The company's EPS (earnings per share; the profit per share) has also been steadily increasing, sitting at a current $0.71 from $0.48 in 2024, showing an impressive 47.9% increase despite concerns. The company also has a strong EBITDA (earnings before interest, taxes, depreciation, and amortization) of $118.06 million. IMAX’s EBITDA margin (EBITDA as a portion of revenue) is roughly 31.3%. While this is strong, it is important to note that EBITDA margins can often be misleading for companies with a large amount of debt. However, IMAX’s strong FCF (about $71.09 million) and its asset light model help refute this, showing strong indications of its profitability. In fact, the company has a debt/EBITDA ratio of about 2.18, which shows the company is financially stable and does not have an abnormal amount of debt. Another ratio that also shows that IMAX is appropriately valued is the Enterprise Value (EV)/EBITDA.The ratio is a good measure of a stock’s appropriate valuation. At 18.02, the company’s valuation seems to be appropriate considering its recent acclaim and the risks mentioned. The ratio is not high enough to cause alarms about overinflation of the company’s value nor is it low enough to raise questions about underlying risks. After examining the qualitative factors along with the ratio, IMAX does mostly appear to be fairly valued.
Disclaimer: The information provided in this article is for informational purposes only and is based on publicly available sources believed to be reliable. While efforts have been made to ensure accuracy, no representation or warranty, express or implied, is made as to the completeness or reliability of the information. Neither the author nor any affiliated parties shall be held liable for any errors, omissions, or outcomes resulting from the use of this material. This article does not constitute financial advice, investment guidance, or a solicitation to buy or sell securities.




Comments